06 January 2025
: Case report 
Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment, Adverse events of drug therapy
Timothy Mark Earls Davis12ABCDEFG*DOI: 10.12659/AJCR.946539
Am J Case Rep 2025; 26:e946539
Table 1. Laboratory test results on admission to the hospital.
| Variable | Admission value | Reference interval |
|---|---|---|
| Serum sodium | 138 mmol/L | 135–145 mmol/L |
| Serum potassium | 4.2 mmol/L | 3.5–5.2 mmol/L |
| Serum bicarbonate | 18 mmol/L | 22–32 mmol/L |
| Serum urea | 6.4 mmol/L | 4.0–9.0 mmol/L |
| Serum creatinine | 87 μmol/L | 45–90 μmol/L |
| Estimated glomerular filtration rate | 56 mL/min/1.73 m | >60 mL/min/1.73 m |
| Serum albumin | 33 g/L | 35–50 g/L |
| Serum magnesium | <0.3 mmol/L | 0.7–1.1 mmol/L |
| Serum total corrected calcium | 1.90 mmol/L | 2.10–2.60 mmol/L |
| Serum ionized calcium | 0.85 mmol/L | 1.15–1.30 mmol/L |
| Serum glucose | 11.5 mmol/L | 3.5–6.9 mmol/L |
| Blood lactate | 2.2 mmol/L | 0.4–2.0 mmol/L |
| HbA | 8.6% (70 mmol/mol) | <6.0% (<42 mmol/mol) |